Searched for
AMIR ATTARAN
IPR won't be part of model law on fake drugs, says UN armThe model legislative provisions have no relation to intellectual property rights and do not apply to unintentional quality defects.- India-led BRICS opposes UN arm’s move on model drug lawUNODC had last week held closed-door meetings in Vienna to firm up a model law prescribing harsh penalties for ‘falsified’ drug-related cri...
- Report on Indian drug makers: India's legal threat a 'shocking overreaction', say US researchersNot even North Korea or Russia have taken the illiberal step of suing scholars for publishing academic research and India.
- Government considering legal action against US think-tank for running smear campaign against Indian pharma industryLegal consultation is being pursued through India Brand Equity Foundation and preliminary opinion of our legal counsel has advised us to do...
- US Food and Drug Administration okays safety of Indian medicinesThe US drug regulator says it has detected no impurity in the Indian version of cholesterol-lowering generic drug Atorvastatin in recent te...
- 2.3 per cent of Indian drugs found sub-standard, US doctors raise doubts on qualityThis latest set of data from the government comes amidst doubts raised by a section of American doctors and academicians over the quality o...
- Ranbaxy whistleblower shares his experiences with US lawmakers“My case against Ranbaxy and what happened with Heparin in China show unscrupulous actors in global supply chain take advantage of gaps in ...
Load More